21 Mar FORTEO safely and effectively. See full prescribing information for FORTEO. FORTEO (teriparatide [rDNA origin] injection) for subcutaneous. HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use FORTEO safely and effectively. See full. One pre-filled pen of mL contains micrograms of teriparatide .. Detailed information on this medicinal product is available on the website of the.
|Published (Last):||26 July 2006|
|PDF File Size:||5.61 Mb|
|ePub File Size:||13.66 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hypersensitivity to teriparatide or to any of its excipients. I am a patient or friend, family member, or other non-prescribing caregiver.
You clicked forteo prescribing information page that’s meant for healthcare providers This section includes technical information. The most common adverse reactions in clinical trials include: If active urolithiasis or pre-existing hypercalciuria are suspected, measurement of urinary calcium excretion should be considered.
The link you clicked will take you to a site maintained by a third party, which is solely responsible for its content. The effect was observed at systemic exposures to teriparatide ranging forteo prescribing information 3 to 60 times the exposure in humans given a mcg dose.
It is not known whether teriparatide is excreted in human milk. Getting closer to your daily goals means so much. The following categories of patients have increased baseline risk of osteosarcoma and therefore should not be treated with FORTEO: FORTEO is indicated forteo prescribing information the treatment of postmenopausal women informatiion osteoporosis at high risk for fracture, to increase bone mass forteo prescribing information men with primary or hypogonadal osteoporosis at high risk for fracture, and for the treatment of men and forteo prescribing information with osteoporosis associated with sustained, systemic glucocorticoid therapy daily dosage equivalent to 5 mg or greater of prednisone at high risk for fracture.
FORTEO is provided as a fixed-dose, prefilled delivery device that can be used for up to 28 days, including the first injection.
Quality time with your buddy means so forteo prescribing information. In male and female rats, teriparatide caused an increase in the incidence of osteosarcoma a malignant bone tumor that was dependent on dose and treatment duration. FORTEO forteo prescribing information be administered initially under circumstances where the ptescribing can sit or lie down if symptoms of orthostatic hypotension occur. Reactions have included angioedema and anaphylaxis.
See Rules and Restrictions for eligibility requirements.
FDA Internet Application Site (Accessdata) Error
FORTEO is used in both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones, or fractures. Other adverse reactions include: Breastfeeding forteo prescribing information should discontinue nursing or FORTEO, taking into account the importance of treatment to the mother.
Fotreo not transfer the contents forteo prescribing information the delivery device into a syringe. Going shopping for what you need means so much.
TGA eBS – Product and Consumer Medicine Information
Before you forteo prescribing information FORTEO, you should tell your healthcare provider if you have Paget’s disease of bone, are a child or young adult whose bones are still growing, or have had radiation forteo prescribing information. FORTEO can be used by people who have had a fracture related to osteoporosis, or who have several risk factors for fracture, or who cannot use other osteoporosis treatments.
Use with caution in patients with active or recent urolithiasis because of risk of exacerbation.
The link you clicked will take you to a site maintained by a third party, which is solely responsible for its content. Potential Risk of Osteosarcoma Possible bone cancer. FORTEO is a prescription medication used in both men and postmenopausal women with osteoporosis who are at high risk forteo prescribing information having broken bones, or fractures.
FORTEO should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.